C
Thermo Fisher Scientific Inc.
TMO
$512.65
-$1.55-0.30%
C
Hold
11/4/2024Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 11/4/2024 due to a noticeable decline in the growth index, total return index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 11/4/2024 due to a noticeable decline in the growth index, total return index and volatility index.
C
Hold
8/5/2024Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 8/5/2024 due to a substantial increase in the growth index, solvency index and valuation index. Operating cash flow increased 56.67% from $1.25B to $1.96B, earnings per share increased from $3.46 to $4.04, and EBIT increased 5.8% from $1.73B to $1.83B.
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 8/5/2024 due to a substantial increase in the growth index, solvency index and valuation index. Operating cash flow increased 56.67% from $1.25B to $1.96B, earnings per share increased from $3.46 to $4.04, and EBIT increased 5.8% from $1.73B to $1.83B.
C
Hold
8/2/2024Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 8/2/2024 due to a decline in the valuation index, efficiency index and growth index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 8/2/2024 due to a decline in the valuation index, efficiency index and growth index.
C
Hold
7/12/2024Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 7/12/2024 due to an increase in the valuation index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 7/12/2024 due to an increase in the valuation index.
C
Hold
6/26/2024Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 6/26/2024 due to a noticeable decline in the growth index and efficiency index. Operating cash flow declined 66.4% from $3.72B to $1.25B, net income declined 18.53% from $1.63B to $1.33B, and earnings per share declined from $4.2 to $3.46.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 6/26/2024 due to a noticeable decline in the growth index and efficiency index. Operating cash flow declined 66.4% from $3.72B to $1.25B, net income declined 18.53% from $1.63B to $1.33B, and earnings per share declined from $4.2 to $3.46.
C
Hold
3/28/2024Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 3/28/2024 due to an increase in the total return index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 3/28/2024 due to an increase in the total return index and volatility index.
C
Hold
2/23/2024Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 2/23/2024 due to a substantial decline in the growth index and efficiency index. Earnings per share declined from $4.42 to $4.2, and net income declined 4.96% from $1.72B to $1.63B.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 2/23/2024 due to a substantial decline in the growth index and efficiency index. Earnings per share declined from $4.42 to $4.2, and net income declined 4.96% from $1.72B to $1.63B.
C
Hold
2/9/2024Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 2/9/2024 due to an increase in the total return index, valuation index and solvency index. The quick ratio increased from 0.89 to 1.13.
Thermo Fisher Scientific Inc. (TMO) was upgraded to C+ from C on 2/9/2024 due to an increase in the total return index, valuation index and solvency index. The quick ratio increased from 0.89 to 1.13.
C
Hold
9/27/2023Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 9/27/2023 due to a noticeable decline in the volatility index, total return index and efficiency index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C from C+ on 9/27/2023 due to a noticeable decline in the volatility index, total return index and efficiency index.
C
Hold
5/8/2023Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C+ from B on 5/8/2023 due to a substantial decline in the growth index, valuation index and solvency index. Operating cash flow declined 79.09% from $3.49B to $729M, the quick ratio declined from 1.06 to 0.8, and earnings per share declined from $3.9855 to $3.32.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C+ from B on 5/8/2023 due to a substantial decline in the growth index, valuation index and solvency index. Operating cash flow declined 79.09% from $3.49B to $729M, the quick ratio declined from 1.06 to 0.8, and earnings per share declined from $3.9855 to $3.32.
B
Buy
2/24/2023Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B from B- on 2/24/2023 due to a noticeable increase in the growth index, volatility index and valuation index. Operating cash flow increased 80.02% from $1.94B to $3.49B, EBIT increased 15.61% from $1.75B to $2.02B, and total revenue increased 7.24% from $10.68B to $11.45B.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B from B- on 2/24/2023 due to a noticeable increase in the growth index, volatility index and valuation index. Operating cash flow increased 80.02% from $1.94B to $3.49B, EBIT increased 15.61% from $1.75B to $2.02B, and total revenue increased 7.24% from $10.68B to $11.45B.
B
Buy
1/23/2023Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B- from C+ on 1/23/2023 due to an increase in the volatility index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B- from C+ on 1/23/2023 due to an increase in the volatility index.
C
Hold
11/21/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to C+ from B- on 11/21/2022 due to a decline in the volatility index, valuation index and solvency index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to C+ from B- on 11/21/2022 due to a decline in the volatility index, valuation index and solvency index.
B
Buy
10/26/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B- from B on 10/26/2022 due to a noticeable decline in the total return index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B- from B on 10/26/2022 due to a noticeable decline in the total return index and volatility index.
B
Buy
10/11/2022Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B from B- on 10/11/2022 due to an increase in the valuation index and total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B from B- on 10/11/2022 due to an increase in the valuation index and total return index.
B
Buy
9/23/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B- from B on 9/23/2022 due to a large decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B- from B on 9/23/2022 due to a large decline in the total return index.
B
Buy
8/23/2022Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B from B- on 8/23/2022 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B from B- on 8/23/2022 due to a large increase in the total return index.
B
Buy
8/8/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B- from B on 8/8/2022 due to a major decline in the growth index, volatility index and valuation index. Operating cash flow declined 30.61% from $2.2B to $1.53B, EBIT declined 26.93% from $2.84B to $2.08B, and earnings per share declined from $5.61 to $4.22.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B- from B on 8/8/2022 due to a major decline in the growth index, volatility index and valuation index. Operating cash flow declined 30.61% from $2.2B to $1.53B, EBIT declined 26.93% from $2.84B to $2.08B, and earnings per share declined from $5.61 to $4.22.
B
Buy
3/25/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 3/25/2022 due to a decline in the growth index, valuation index and solvency index. The quick ratio declined from 2.37 to 1, debt to equity increased from 0.56 to 0.86, and earnings per share declined from $4.79 to $4.1595.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 3/25/2022 due to a decline in the growth index, valuation index and solvency index. The quick ratio declined from 2.37 to 1, debt to equity increased from 0.56 to 0.86, and earnings per share declined from $4.79 to $4.1595.
B
Buy
2/25/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 2/25/2022 due to a decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 2/25/2022 due to a decline in the total return index.
A
Buy
1/31/2022Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 1/31/2022 due to a substantial decline in the total return index, solvency index and efficiency index. Debt to equity increased from 0.51 to 0.56.
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 1/31/2022 due to a substantial decline in the total return index, solvency index and efficiency index. Debt to equity increased from 0.51 to 0.56.
A
Buy
10/22/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/22/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/22/2021 due to a large increase in the total return index.
B
Buy
10/20/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 10/20/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 10/20/2021 due to a large decline in the total return index and valuation index.
A
Buy
10/15/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/15/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/15/2021 due to a large increase in the total return index.
B
Buy
10/13/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 10/13/2021 due to a large decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 10/13/2021 due to a large decline in the total return index.
A
Buy
10/8/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/8/2021 due to a large increase in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/8/2021 due to a large increase in the total return index and valuation index.
B
Buy
10/6/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 10/6/2021 due to a large decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 10/6/2021 due to a large decline in the total return index.
A
Buy
10/1/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/1/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 10/1/2021 due to a large increase in the total return index.
B
Buy
9/29/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/29/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/29/2021 due to a large decline in the total return index and valuation index.
A
Buy
9/24/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/24/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/24/2021 due to a large increase in the total return index.
B
Buy
9/22/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/22/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/22/2021 due to a large decline in the total return index and valuation index.
A
Buy
9/17/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/17/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/17/2021 due to a large increase in the total return index.
B
Buy
9/15/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/15/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/15/2021 due to a large decline in the total return index and valuation index.
A
Buy
9/10/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/10/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/10/2021 due to a large increase in the total return index.
B
Buy
9/8/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/8/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 9/8/2021 due to a large decline in the total return index and valuation index.
A
Buy
9/2/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/2/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 9/2/2021 due to a large increase in the total return index.
B
Buy
8/31/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 8/31/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 8/31/2021 due to a large decline in the total return index and valuation index.
A
Buy
8/26/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 8/26/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 8/26/2021 due to a large increase in the total return index.
B
Buy
8/24/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 8/24/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 8/24/2021 due to a large decline in the total return index and valuation index.
A
Buy
8/19/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 8/19/2021 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from B+ on 8/19/2021 due to a large increase in the total return index.
B
Buy
8/17/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 8/17/2021 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A on 8/17/2021 due to a large decline in the total return index and valuation index.
A
Buy
8/16/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 8/16/2021 due to a noticeable increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 8/16/2021 due to a noticeable increase in the total return index.
A
Buy
8/9/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 8/9/2021 due to a large increase in the total return index, growth index and solvency index. The quick ratio increased from 1.7 to 1.92, operating cash flow increased 12.59% from $1.98B to $2.23B, and debt to equity declined from 0.53 to 0.51.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 8/9/2021 due to a large increase in the total return index, growth index and solvency index. The quick ratio increased from 1.7 to 1.92, operating cash flow increased 12.59% from $1.98B to $2.23B, and debt to equity declined from 0.53 to 0.51.
B
Buy
6/25/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 6/25/2021 due to an increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 6/25/2021 due to an increase in the total return index.
B
Buy
5/25/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 5/25/2021 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 40.76% from $3.34B to $1.98B, total revenue declined 6.1% from $10.55B to $9.91B, and earnings per share declined from $6.2344 to $5.88.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 5/25/2021 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 40.76% from $3.34B to $1.98B, total revenue declined 6.1% from $10.55B to $9.91B, and earnings per share declined from $6.2344 to $5.88.
B
Buy
5/3/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 5/3/2021 due to a decline in the total return index, volatility index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 5/3/2021 due to a decline in the total return index, volatility index and valuation index.
A
Buy
4/16/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 4/16/2021 due to an increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 4/16/2021 due to an increase in the total return index.
B
Buy
3/15/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 3/15/2021 due to a decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 3/15/2021 due to a decline in the total return index.
A
Buy
2/26/2021Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 2/26/2021 due to a noticeable increase in the valuation index, efficiency index and solvency index. Net income increased 29.23% from $1.93B to $2.5B, total capital increased 7.87% from $52.93B to $57.1B, and debt to equity declined from 0.66 to 0.64.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 2/26/2021 due to a noticeable increase in the valuation index, efficiency index and solvency index. Net income increased 29.23% from $1.93B to $2.5B, total capital increased 7.87% from $52.93B to $57.1B, and debt to equity declined from 0.66 to 0.64.
B
Buy
1/27/2021Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 1/27/2021 due to a noticeable decline in the total return index, valuation index and efficiency index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 1/27/2021 due to a noticeable decline in the total return index, valuation index and efficiency index.
B
Buy
10/30/2020Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 10/30/2020 due to a major increase in the total return index, growth index and solvency index. Earnings per share increased from $2.9 to $4.84, EBIT increased 65.1% from $1.45B to $2.39B, and operating cash flow increased 43.58% from $1.89B to $2.71B.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 10/30/2020 due to a major increase in the total return index, growth index and solvency index. Earnings per share increased from $2.9 to $4.84, EBIT increased 65.1% from $1.45B to $2.39B, and operating cash flow increased 43.58% from $1.89B to $2.71B.
B
Buy
4/17/2020Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 4/17/2020 due to a decline in the total return index, valuation index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 4/17/2020 due to a decline in the total return index, valuation index and volatility index.
B
Buy
4/7/2020Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 4/7/2020 due to a decline in the volatility index and total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 4/7/2020 due to a decline in the volatility index and total return index.
A
Buy
2/28/2020Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 2/28/2020 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 71.26% from $1.12B to $1.91B, earnings per share increased from $1.88 to $2.4962, and EBIT increased 28.82% from $989M to $1.27B.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 2/28/2020 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 71.26% from $1.12B to $1.91B, earnings per share increased from $1.88 to $2.4962, and EBIT increased 28.82% from $989M to $1.27B.
B
Buy
2/21/2020Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from A- on 2/21/2020 due to a large decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from A- on 2/21/2020 due to a large decline in the total return index.
A
Buy
2/20/2020Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 2/20/2020 due to a large increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 2/20/2020 due to a large increase in the total return index.
B
Buy
2/13/2020Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from A- on 2/13/2020 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from A- on 2/13/2020 due to a large decline in the total return index and valuation index.
A
Buy
2/12/2020Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 2/12/2020 due to a noticeable increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 2/12/2020 due to a noticeable increase in the total return index.
B
Buy
12/30/2019Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 12/30/2019 due to an increase in the total return index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 12/30/2019 due to an increase in the total return index and volatility index.
B
Buy
12/6/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 12/6/2019 due to a decline in the valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 12/6/2019 due to a decline in the valuation index.
B
Buy
11/20/2019Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 11/20/2019 due to an increase in the volatility index and total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 11/20/2019 due to an increase in the volatility index and total return index.
B
Buy
11/5/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 11/5/2019 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from $2.77 to $1.88, operating cash flow declined 13.68% from $1.29B to $1.12B, and EBIT declined 5.81% from $1.05B to $989M.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 11/5/2019 due to a noticeable decline in the growth index and valuation index. Earnings per share declined from $2.77 to $1.88, operating cash flow declined 13.68% from $1.29B to $1.12B, and EBIT declined 5.81% from $1.05B to $989M.
B
Buy
10/10/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 10/10/2019 due to a decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 10/10/2019 due to a decline in the total return index and valuation index.
A
Buy
8/19/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 8/19/2019 due to a decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 8/19/2019 due to a decline in the total return index.
A
Buy
8/2/2019Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 8/2/2019 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 99.38% from $649M to $1.29B, net income increased 37.3% from $815M to $1.12B, and earnings per share increased from $2.02 to $2.77.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 8/2/2019 due to a noticeable increase in the growth index, valuation index and efficiency index. Operating cash flow increased 99.38% from $649M to $1.29B, net income increased 37.3% from $815M to $1.12B, and earnings per share increased from $2.02 to $2.77.
A
Buy
7/25/2019Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 7/25/2019 due to an increase in the valuation index and total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 7/25/2019 due to an increase in the valuation index and total return index.
B
Buy
7/15/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 7/15/2019 due to a decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 7/15/2019 due to a decline in the total return index and valuation index.
B
Buy
6/26/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 6/26/2019 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 63.96% from $1.8B to $649M, EBIT declined 21.52% from $1.21B to $948M, and earnings per share declined from $2.2155 to $2.02.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 6/26/2019 due to a noticeable decline in the growth index, total return index and volatility index. Operating cash flow declined 63.96% from $1.8B to $649M, EBIT declined 21.52% from $1.21B to $948M, and earnings per share declined from $2.2155 to $2.02.
A
Buy
4/24/2019Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 4/24/2019 due to an increase in the total return index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 4/24/2019 due to an increase in the total return index.
B
Buy
3/29/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 3/29/2019 due to a decline in the valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 3/29/2019 due to a decline in the valuation index.
A
Buy
3/4/2019Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 3/4/2019 due to a large increase in the growth index, total return index and solvency index. Operating cash flow increased 47.62% from $1.22B to $1.8B, EBIT increased 37.39% from $880M to $1.21B, and earnings per share increased from $1.75 to $2.2155.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B on 3/4/2019 due to a large increase in the growth index, total return index and solvency index. Operating cash flow increased 47.62% from $1.22B to $1.8B, EBIT increased 37.39% from $880M to $1.21B, and earnings per share increased from $1.75 to $2.2155.
B
Buy
1/3/2019Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 1/3/2019 due to a large decline in the total return index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 1/3/2019 due to a large decline in the total return index and volatility index.
B
Buy
12/19/2018Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 12/19/2018 due to a decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 12/19/2018 due to a decline in the total return index and valuation index.
A
Buy
11/6/2018Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 11/6/2018 due to a noticeable increase in the total return index, valuation index and solvency index. The quick ratio increased from 0.98 to 1.12, and debt to equity declined from 0.74 to 0.7.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 11/6/2018 due to a noticeable increase in the total return index, valuation index and solvency index. The quick ratio increased from 0.98 to 1.12, and debt to equity declined from 0.74 to 0.7.
B
Buy
10/1/2018Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 10/1/2018 due to a large increase in the growth index, solvency index and volatility index. Operating cash flow increased 1,751.28% from $78M to $1.44B, earnings per share increased from $1.43 to $1.85, and the quick ratio increased from 0.77 to 0.98.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 10/1/2018 due to a large increase in the growth index, solvency index and volatility index. Operating cash flow increased 1,751.28% from $78M to $1.44B, earnings per share increased from $1.43 to $1.85, and the quick ratio increased from 0.77 to 0.98.
B
Buy
5/8/2018Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 5/8/2018 due to a decline in the growth index, valuation index and volatility index. Operating cash flow declined 95.82% from $1.87B to $78M, EBIT declined 13.08% from $968.7M to $842M, and total revenue declined 3.21% from $6.05B to $5.85B.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 5/8/2018 due to a decline in the growth index, valuation index and volatility index. Operating cash flow declined 95.82% from $1.87B to $78M, EBIT declined 13.08% from $968.7M to $842M, and total revenue declined 3.21% from $6.05B to $5.85B.
B
Buy
3/26/2018Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 3/26/2018 due to an increase in the total return index and solvency index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 3/26/2018 due to an increase in the total return index and solvency index.
B
Buy
3/8/2018Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 3/8/2018 due to a decline in the valuation index, growth index and efficiency index. Earnings per share declined from $1.34 to $1.3069, net income declined 1.09% from $533.9M to $528.1M, and total capital declined 0.53% from $46.79B to $46.55B.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from B+ on 3/8/2018 due to a decline in the valuation index, growth index and efficiency index. Earnings per share declined from $1.34 to $1.3069, net income declined 1.09% from $533.9M to $528.1M, and total capital declined 0.53% from $46.79B to $46.55B.
B
Buy
2/15/2018Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 2/15/2018 due to an increase in the valuation index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 2/15/2018 due to an increase in the valuation index.
B
Buy
1/31/2018Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from A- on 1/31/2018 due to a decline in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B from A- on 1/31/2018 due to a decline in the total return index and valuation index.
A
Buy
12/12/2017Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 12/12/2017 due to a decline in the total return index.
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 12/12/2017 due to a decline in the total return index.
A
Buy
11/21/2017Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 11/21/2017 due to an increase in the total return index and valuation index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 11/21/2017 due to an increase in the total return index and valuation index.
A
Buy
11/6/2017Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 11/6/2017 due to a decline in the growth index, solvency index and efficiency index. Debt to equity increased from 0.75 to 0.89, the quick ratio declined from 0.84 to 0.7, and earnings per share declined from $1.5585 to $1.34.
Thermo Fisher Scientific Inc. (TMO) was downgraded to A- from A on 11/6/2017 due to a decline in the growth index, solvency index and efficiency index. Debt to equity increased from 0.75 to 0.89, the quick ratio declined from 0.84 to 0.7, and earnings per share declined from $1.5585 to $1.34.
A
Buy
10/3/2017Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 10/3/2017 due to a noticeable increase in the total return index, solvency index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A from A- on 10/3/2017 due to a noticeable increase in the total return index, solvency index and volatility index.
A
Buy
8/4/2017Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 8/4/2017 due to an increase in the growth index, total return index and solvency index. Operating cash flow increased 134.69% from $361.5M to $848.4M, earnings per share increased from $1.4 to $1.5585, and EBIT increased 10.33% from $708.3M to $781.5M.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 8/4/2017 due to an increase in the growth index, total return index and solvency index. Operating cash flow increased 134.69% from $361.5M to $848.4M, earnings per share increased from $1.4 to $1.5585, and EBIT increased 10.33% from $708.3M to $781.5M.
B
Buy
5/10/2017Downgrade
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 5/10/2017 due to a large decline in the growth index. Operating cash flow declined 70.02% from $1.21B to $361.5M, EBIT declined 14.36% from $827.1M to $708.3M, and earnings per share declined from $1.5918 to $1.4.
Thermo Fisher Scientific Inc. (TMO) was downgraded to B+ from A- on 5/10/2017 due to a large decline in the growth index. Operating cash flow declined 70.02% from $1.21B to $361.5M, EBIT declined 14.36% from $827.1M to $708.3M, and earnings per share declined from $1.5918 to $1.4.
A
Buy
3/8/2017Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 3/8/2017 due to an increase in the total return index and volatility index.
Thermo Fisher Scientific Inc. (TMO) was upgraded to A- from B+ on 3/8/2017 due to an increase in the total return index and volatility index.
B
Buy
3/3/2017Upgraded
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 3/3/2017 due to a large increase in the growth index, total return index and efficiency index. Operating cash flow increased 56.25% from $771.8M to $1.21B, earnings per share increased from $1.19 to $1.5918, and net income increased 32.95% from $473.5M to $629.5M.
Thermo Fisher Scientific Inc. (TMO) was upgraded to B+ from B on 3/3/2017 due to a large increase in the growth index, total return index and efficiency index. Operating cash flow increased 56.25% from $771.8M to $1.21B, earnings per share increased from $1.19 to $1.5918, and net income increased 32.95% from $473.5M to $629.5M.
B
Buy
11/7/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B from B+ on 11/7/2016 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 13.23% from $889.5M to $771.8M, earnings per share declined from $1.2995 to $1.19, and EBIT declined 3.07% from $687.3M to $666.2M.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B from B+ on 11/7/2016 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 13.23% from $889.5M to $771.8M, earnings per share declined from $1.2995 to $1.19, and EBIT declined 3.07% from $687.3M to $666.2M.
B
Buy
10/27/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 10/27/2016 due to a noticeable decline in the total return index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 10/27/2016 due to a noticeable decline in the total return index and volatility index.
A
Buy
10/24/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 10/24/2016 due to a noticeable decline in the total return index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 10/24/2016 due to a noticeable decline in the total return index and volatility index.
A
Buy
9/27/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from B+ on 9/27/2016 due to a substantial increase in the total return index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from B+ on 9/27/2016 due to a substantial increase in the total return index and volatility index.
B
Buy
9/14/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 9/14/2016 due to a decline in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 9/14/2016 due to a decline in the total return index.
A
Buy
9/12/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 9/12/2016 due to a decline in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 9/12/2016 due to a decline in the total return index.
A
Buy
9/9/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A from A+ on 9/9/2016 due to a substantial decline in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A from A+ on 9/9/2016 due to a substantial decline in the total return index.
A
Buy
8/12/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A on 8/12/2016 due to a large increase in the total return index, solvency index and valuation index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A on 8/12/2016 due to a large increase in the total return index, solvency index and valuation index.
A
Buy
8/5/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 8/5/2016 due to a large increase in the growth index, solvency index and efficiency index. Operating cash flow increased 207.68% from $289.1M to $889.5M, earnings per share increased from $1.0097 to $1.2995, and net income increased 28.44% from $402.2M to $516.6M.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 8/5/2016 due to a large increase in the growth index, solvency index and efficiency index. Operating cash flow increased 207.68% from $289.1M to $889.5M, earnings per share increased from $1.0097 to $1.2995, and net income increased 28.44% from $402.2M to $516.6M.
A
Buy
8/2/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A+ on 8/2/2016 due to a large decline in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A+ on 8/2/2016 due to a large decline in the total return index.
A
Buy
8/1/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A- on 8/1/2016 due to a large increase in the total return index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A- on 8/1/2016 due to a large increase in the total return index and volatility index.
A
Buy
7/29/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A+ on 7/29/2016 due to a large decline in the total return index and valuation index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A+ on 7/29/2016 due to a large decline in the total return index and valuation index.
A
Buy
7/28/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A on 7/28/2016 due to a noticeable increase in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A on 7/28/2016 due to a noticeable increase in the total return index.
A
Buy
5/23/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 5/23/2016 due to an increase in the total return index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 5/23/2016 due to an increase in the total return index and volatility index.
A
Buy
5/6/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 5/6/2016 due to a noticeable decline in the growth index, solvency index and efficiency index. Operating cash flow declined 76.46% from $1.23B to $289.1M, net income declined 33.26% from $602.6M to $402.2M, and earnings per share declined from $1.5006 to $1.0097.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 5/6/2016 due to a noticeable decline in the growth index, solvency index and efficiency index. Operating cash flow declined 76.46% from $1.23B to $289.1M, net income declined 33.26% from $602.6M to $402.2M, and earnings per share declined from $1.5006 to $1.0097.
A
Buy
4/28/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 4/28/2016 due to an increase in the volatility index and total return index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 4/28/2016 due to an increase in the volatility index and total return index.
A
Buy
4/13/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 4/13/2016 due to a decline in the total return index and valuation index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 4/13/2016 due to a decline in the total return index and valuation index.
A
Buy
3/28/2016Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A from A+ on 3/28/2016 due to a decline in the total return index and valuation index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A from A+ on 3/28/2016 due to a decline in the total return index and valuation index.
A
Buy
3/11/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A on 3/11/2016 due to a noticeable increase in the total return index and solvency index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A+ from A on 3/11/2016 due to a noticeable increase in the total return index and solvency index.
A
Buy
2/26/2016Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 2/26/2016 due to a noticeable increase in the total return index, growth index and valuation index. Operating cash flow increased 65.09% from $743.9M to $1.23B, earnings per share increased from $1.187 to $1.5006, and EBIT increased 20.37% from $603.8M to $726.8M.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 2/26/2016 due to a noticeable increase in the total return index, growth index and valuation index. Operating cash flow increased 65.09% from $743.9M to $1.23B, earnings per share increased from $1.187 to $1.5006, and EBIT increased 20.37% from $603.8M to $726.8M.
A
Buy
12/30/2015Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 12/30/2015 due to an increase in the total return index, volatility index and solvency index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 12/30/2015 due to an increase in the total return index, volatility index and solvency index.
B
Buy
10/30/2015Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 10/30/2015 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from $1.27 to $1.187, total revenue declined 3.46% from $4.27B to $4.12B, and operating cash flow declined 2.75% from $764.9M to $743.9M.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 10/30/2015 due to a large decline in the growth index, volatility index and total return index. Earnings per share declined from $1.27 to $1.187, total revenue declined 3.46% from $4.27B to $4.12B, and operating cash flow declined 2.75% from $764.9M to $743.9M.
A
Buy
8/26/2015Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 8/26/2015 due to a decline in the total return index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 8/26/2015 due to a decline in the total return index and volatility index.
A
Buy
8/11/2015Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 8/11/2015 due to an increase in the total return index, volatility index and solvency index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 8/11/2015 due to an increase in the total return index, volatility index and solvency index.
A
Buy
7/31/2015Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 7/31/2015 due to a major increase in the growth index, solvency index and valuation index. Operating cash flow increased 856.12% from $80M to $764.9M, earnings per share increased from $0.96 to $1.27, and EBIT increased 17.61% from $527.5M to $620.4M.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 7/31/2015 due to a major increase in the growth index, solvency index and valuation index. Operating cash flow increased 856.12% from $80M to $764.9M, earnings per share increased from $0.96 to $1.27, and EBIT increased 17.61% from $527.5M to $620.4M.
B
Buy
5/1/2015Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 5/1/2015 due to a substantial decline in the growth index, solvency index and valuation index. Operating cash flow declined 91.61% from $953.7M to $80M, earnings per share declined from $1.4912 to $0.96, and the quick ratio declined from 0.72 to 0.5.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 5/1/2015 due to a substantial decline in the growth index, solvency index and valuation index. Operating cash flow declined 91.61% from $953.7M to $80M, earnings per share declined from $1.4912 to $0.96, and the quick ratio declined from 0.72 to 0.5.
A
Buy
4/29/2015Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 4/29/2015 due to a decline in the total return index, valuation index and solvency index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 4/29/2015 due to a decline in the total return index, valuation index and solvency index.
A
Buy
2/27/2015Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 2/27/2015 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 41.08% from $676M to $953.7M, earnings per share increased from $1.1642 to $1.4912, and EBIT increased 24.12% from $551.5M to $684.5M.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 2/27/2015 due to a noticeable increase in the growth index, total return index and valuation index. Operating cash flow increased 41.08% from $676M to $953.7M, earnings per share increased from $1.1642 to $1.4912, and EBIT increased 24.12% from $551.5M to $684.5M.
A
Buy
1/28/2015Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 1/28/2015 due to an increase in the total return index and solvency index.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 1/28/2015 due to an increase in the total return index and solvency index.
B
Buy
11/21/2014Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 11/21/2014 due to a decline in the valuation index and volatility index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 11/21/2014 due to a decline in the valuation index and volatility index.
A
Buy
11/4/2014Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 11/4/2014 due to an increase in the valuation index and growth index. Earnings per share increased from $0.69 to $1.1642.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A- from B+ on 11/4/2014 due to an increase in the valuation index and growth index. Earnings per share increased from $0.69 to $1.1642.
B
Buy
4/25/2014Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 4/25/2014 due to a decline in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to B+ from A- on 4/25/2014 due to a decline in the total return index.
A
Buy
4/21/2014Downgrade
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 4/21/2014 due to a noticeable decline in the total return index.
Thermo Fisher Scientific, Inc. (TMO) was downgraded to A- from A on 4/21/2014 due to a noticeable decline in the total return index.
A
Buy
4/3/2014Upgraded
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 4/3/2014 due to a noticeable increase in the growth index, total return index and solvency index. The quick ratio increased from 1.55 to 2.49, operating cash flow increased 44.11% from $505.5M to $728.5M, and EBIT increased 17.95% from $428.4M to $505.3M.
Thermo Fisher Scientific, Inc. (TMO) was upgraded to A from A- on 4/3/2014 due to a noticeable increase in the growth index, total return index and solvency index. The quick ratio increased from 1.55 to 2.49, operating cash flow increased 44.11% from $505.5M to $728.5M, and EBIT increased 17.95% from $428.4M to $505.3M.
NYSE
03/12/2025 4:00PM Eastern
Quotes delayed
